Up and down the next day, the two news shock pharmaceutical stock market, the current capital market investment advice

Introduction: Why does unnamed medicine repeatedly emphasize the non-equity relationship between the company and Kexing Zhongwei?New1:
May 10 at the Beijing branch of China Brand Day, Kexing Holdings Chairman Yan Weidong told the media that the new coronavirus inactivated vaccine developed by Kexing has completed the first phase of the second phase of clinical trials, is expected to be trial production in Julythe next day, because the nameof medicine seems to be with Kexing's "smear", the opening of the day's unnamed medicine opened a word up and downThere were 1682 million lots of purchases in the queue, and the amount of money accumulated was as high as 363 million yuanMay 13, unnamed pharma announced that the company has no equity relationship with Zhongwei Biotechnology Co., Ltd., which is not in Beijingpicture source: The official announcement of the name of the medicine
but even so, as of may 13 close, the nameless medicine still ushered in the third day of gains, and since February this year, the rise has exceeded 175 percentInvestors seem to deliberately ignore the content sinopia, and the specific in the end "unnamed medicine" and "new crown vaccine" has a relationship, may not only the author confused, interested friends can explore one or two in the eyes of the sky, again do not do too much detailPicture: Oriental Wealth.
New2:
May 11, Wuhan New Crown Pneumonia Outbreak Prevention and Control Command epidemic-related big data and epidemiology investigation team issued "on the implementation of the city's new coronavirus nucleic acid screening emergency notice" (hereinafter referred to as "emergency notice"), which informed Wuhan District New Coronary Pneumonia Outbreak Prevention and Control Command: after research decision, in Wuhan City-wide to carry out a full new coronavirus nucleic acid screening "10-day General Assembly War." Each district according to the 10-day period, do a good job in this jurisdiction of the full nucleic acid screening program arrangements12 morning, the new crown pneumonia monitoring concept rose alarmingly, the index straight below 4%, as of May 12, the close, Mike Bio, Nine Biology, Mingde Biological and many other ups and downs, Da'an gene rose more than 9%, Shushi Bio, Huada gene and other stocks have also pulled up13, the concept gradually digested, the extent of the closing increase called the previous day's decline significantly, Mingde, Huada, Da'an and other three enterprises fell seriously, while in the previous few days in Hubei Province announced the new corona pneumonia nucleic acid testing reagents in the winning enterprises only Mike biostock market still showed last week's trendpicture source: Wuhan city official filepicture source: Oriental Wealth APPthe author speculated that this may be due to mike biological in the collection of the price advantage reasonsimilar situation: seems to have knownalthough the news led to the trend of funds, but it seems that the same situation occurred in the previous months, to Ling pharmaceutical industry, unnamed medicine, Da'an biology, etcare the author's focus, and after each rise and fall is also broken the hearts of many retail investors, after the ups and downs, often accompanied by a sharp fall, and the recent request situation also confirmed the author's view, hope that you enter the future later comrades must be careful to avoid risk, as the most striking example of a forward-looking response, the stock market should be the best time to enter the market, before the outbreak, a predictable prediction of the current outbreak, rather than the end of the domestic outbreakAnd the new crown detection concept rose a day after the sharp fall, perhaps also reflects the capital market on the current domestic new crown detection concept of the importance has decreasedUnsurprisingly, after today, if there is no major official news, the new crown detection concept will enter the continuous shock phase, the negative fall began againadvertising: the outbreak of the "best", the stock market investment short-term operation is considerable profit, but if you grasp the overall situation, master the lifeblood of the times, long-term investment is also a good choiceonline a 90-year-after mother once said: "Before the outbreak, I do not know which medicine can cure cold, not to know what 'even flower plague' is what kind of medicine, and now I do not only know these, I also know that Lianhua Qing plague is produced by Ling pharmaceutical industry, not to mention there are many other outbreak-related enterprises."indeed, now society as an information explosion era, is also an era of information, relative to the previous information transmission in a great increase at the same time, information cover-up speed is also accelerating, now the enterprise is worried about whether publicity can reach users, more worried about whether users can remember you, just at this time, the various epidemic-related concepts enterprises use the national public's eyes "focus", is undoubtedly done a life-effective advertising, let the national people remember that you are the most importantOf course, in addition to advertising efficiency, the actual profit income is also full1996, the subsidiary Sanjing Pharmaceuticals made a huge lossJiang Linkui, then director of the factory, was inspired by the fire of the year's 39 stomach Thai, began to try to advertise, the results were surprisingly goodin 1997, Sanjing Pharmaceuticals launched 10 million yuan of advertising, sales reached 100 million yuan, in 1998 20 million ads, sales reached 220 million yuan, in 1999 advertising ads rose sharply to 200 million yuan, sales also soared to 860 million yuanIn 1999, sani Pharmaceuticals' successful model began to grow widely within the Groupso for enterprises, stocks, market value, profits, donations, etc are small profits, as long as the people of the country can know themselves, identify themselves, and more profits is not a dream Of course, again good, big advertising, also need a good business model, I do not know that the pharmaceutical group was destroyed here so final, in short, for the market industry, investment in the new crown epidemic-related pharmaceutical enterprises, individuals think that should be priority long-term investment, compared to today's pharmaceutical stocks, short-term investment risk is really not low, recommended a few options: preferred is not yet available, but also to solve the rigid demand for the outbreak, such as vaccine research and development, special effects drug research and development (the current situation is not clear, the risk is still very large, after all, the success rate of new drug research and development in this and in the dimension may only be a large enterprise the preferred epidemic period advertising role is obvious, and the degree of competition is low, while the company does not have major business problems in the enterprise, such as: Eling Pharmaceuticals, Myer Medical, etc (a year later to see the results) is not related to the epidemic, but in the outbreak period widely affected (production, sales, circulation, etc.) leading enterprises, although such enterprises during the outbreak is severely restricted, the stock price decline is also very obvious, but in the latter quarters of the recovery of the epidemic, relying on its core competitiveness to rise huge space, such as: Hengrui Pharmaceuticals, Fosun Pharma and other enterprises in 2020 have innovative drug listing plans preferred by the era of the emerging pharmaceutical industry, such enterprises also in the outbreak period was affected, but in the "innovation for the king" of the call of the times, the second half of the year must rise huge, recommended: medicine Ming Kant, ZhaoYan new drugs, Corning into and so on responsibility editor , penicillin statement: This article only on behalf of the author himself, does not represent the position of the drug intelligence network, welcome to exchange supplements in the message area; related labels: national , pharmaceutical stock market , capital market 0
0